ACA vs DY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ACA

61.5
AI Score
VS
ACA Wins

DY

33.5
AI Score

Investment Advisor Scores

ACA

62score
Recommendation
BUY

DY

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACA DY Winner
Revenue 1.23B 3.97B DY
Net Income 366.30M 206.93M ACA
Net Margin 29.8% 5.2% ACA
ROE 12.3% 10.0% ACA
ROA 6.9% 3.2% ACA
Total Assets 5.30B 6.54B DY
Cash 432.10M 340.08M ACA
Current Ratio 3.12 2.35 ACA
Free Cash Flow -41.60M -60.75M ACA

Relative Price Performance (Last 90 Days)

ACA 1M: +1.8% · 3M: +2.9% DY 1M: -19.9% · 3M: -47.6%

Current Technical Phase

ACA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.5% over 20 days), RSI 82

RSI (14): 82.2 · Price: $149.15

DY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.4%), weak momentum, RSI 21

RSI (14): 21.5 · Price: $225.16

Fundamentals Snapshot

Metric ACA DY
Market Cap — —
Forward P/E 29.1 16.5
Trailing P/E 36.4 21.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.5%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 4.09 10.95
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.